Profile

Joseph Yeboah, M.B.Ch.B.Wake Forest Baptist Health

Doctor Rating

4.5 out of 5

58 Ratings
6 Comments
 

Joseph Yeboah, M.B.Ch.B.

Assistant Professor,

Clinical Interests

Cardiac Imaging, Preventive Cardiology, Cardiac Magnetic Resonance Imaging, Nuclear Cardiology, Critical Care, Cardiology (clinical), Echocardiography

Contact Information

Request An Appointment

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-6674
Department: 336-716-7015

Insurance Accepted »

Education & Training

  • B.S., University Ghana Medical School-Ghana, 1996
  • M.D., University Ghana Medical School-Ghana, 2000
  • M.S., WFU School of Medicine, 2007
  • Internship, Pediatric Surgery, Korle-Bu Teaching Hos, 2001
  • Internship, Internal Medicine, Korle-Bu Teaching Hos, 2002
  • Internship, Internal Medicine, Hosp Of St Raphael, 2003
  • Residency, Internal Medicine, Hosp Of St Raphael, 2005
  • Fellowship, Cardiology, WFU School of Medicine, 2007
  • Fellowship, Critical Care Medicine, WFU School of Medicine, 2008
  • Fellowship, Internal Medicine, University of Virginia School, 2011

Board Certifications

  • American Board of Internal Medicine, Cardiovascular Disease
  • American Board of Internal Medicine, Critical Care Medicine

Memberships

  • American College of Cardiology
  • Am Heart Association

NPI Number

  • 1134241474
Joseph Yeboah, M.B.Ch.B.

Doctor Rating

4.5 out of 5

58 Ratings
6 Comments
 

Joseph Yeboah, M.B.Ch.B.

Assistant Professor, Cardiology
Epidemiology & Prevention

Research Interests

Cardiovascular Diseases; Brachial Artery; Vasodilation; Atherosclerosis; Coronary Artery Disease
More »

Contact Information

Request An Appointment

Academic: 716 | Department: 336-716-7015

Recent Publications

Diagnostic value of coronary artery calcium score for cardiovascular disease in African Americans: the Jackson Heart Study. Sung JH, Yeboah J, Lee JE, Smith CL, Terry JG, Sims M, Samdarshi T, Musani S, Fox E, Ge Y, Wilson JG, Taylor HA, Carr JJ.. Br J Med Med Res. 2016;11(2):.

Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. Yeboah J, Young R, McClelland RL, Delaney JC, Polonsky TS, Dawood FZ, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC Jr, Psaty BM, Greenland P, Herrington DM.. J Am Coll Cardiol. 2016;67(2):139-147.

Prognosis of low normal left ventricular ejection fraction in an asymptomatic population-based adult cohort: the Multiethnic Study of Atherosclerosis. Yeboah J, Rodriguez CJ, Qureshi W, Liu S, Carr JJ, Lima JA, Hundley WG, Herrington DM.. J Card Fail. 2016;22(10):763-768.

Impact of replacing the Pooled Cohort Equation with other cardiovascular disease risk scores on atherosclerotic cardiovascular disease risk assessment (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Qureshi WT, Michos ED, Flueckiger P, Blaha M, Sandfort V, Herrington DM, Burke G, Yeboah J.. Am J Cardiol. 2016;118(5):691-696.

Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. Townsend RR, Chang TI, Cohen DL, Cushman WC, Evans GW, Glasser SP, Haley WE, Olney C, Oparil S, Del Pinto R, Pisoni R, Taylor AA, Umanath K, Wright JT Jr, Yeboah J.. J Am Soc Hypertens. 2016;10(11):847-856.

Providing evidence for subclinical CVD in risk assessment. Blaha MJ, Yeboah J, Al Rifai M, Liu K, Kronmal R, Greenland P.. Glob Heart. 2016;11(3):275-285.

Postoperative blood urea nitrogen is associated with stroke in cardiac surgical patients. Arnan MK, Hsieh TC, Yeboah J, Bertoni AG, Burke GL, Bahrainwala Z, Grega MA, Baumgartner WA, Gottesman RF.. Ann Thorac Surg. 2015;99(4):1314-1320.

Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function. Chotenimitkhun R, D'Agostino R Jr, Lawrence JA, Hamilton CA, Jordan JH, Vasu S, Lash TL, Yeboah J, Herrington DM, Hundley WG.. Can J Cardiol. 2015;31(3):302-307.

Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA). Yeboah J, Sillau S, Delaney JC, Blaha MJ, Michos ED, Young R, Qureshi WT, McClelland R, Burke GL, Psaty BM, Herrington DM.. Am Heart J. 2015;169(3):387-395.e3.

Transthoracic echocardiography. Yeboah J, Upadhya B. In: Lefebvre C, O'Neill JC, Cline DM, eds. The atlas of cardiovascular emergencies. New York: McGraw-Hill Education;2015: 43-45.

Association of sleep apnea and snoring with incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis. Lin GM, Colangelo LA, Lloyd-Jones DM, Redline S, Yeboah J, Heckbert SR, Nazarian S, Alonso A, Bluemke DA, Punjabi NM, Szklo M, Liu K.. Am J Epidemiol. 2015;182(1):49-57.

Utility of nontraditional risk markers in individuals ineligible for statin therapy according to the 2013 American College of Cardiology/American Heart Association cholesterol guidelines. Yeboah J, Polonsky TS, Young R, McClelland RL, Delaney JC, Dawood F, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC Jr, Psaty BM, Greenland P, Herrington DM.. Circulation. 2015;132(10):916-922.

Coronary artery calcium as a predictor of incident heart failure with preserved ejection fraction: results from the Multi-Ethnic Study of Atherosclerosis (MESA) [abstract]. Sharma K, Ahmed H, Dardari Z, Silverman MG, Yancy CW, Szklo M, Yeboah J, Russell SD, Blumenthal RS, Blaha MJ.. J Card Fail. 2015;21(8 Suppl):S110.

Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention [commentary]. Yeboah J.. Evid Based Med. 2015;20(6):230.

Associations of body composition measures and C2, a marker for small artery elasticity: the MESA. Forbang NI, Allison MA, Ix JH, Criqui MH, Vaidya D, Yeboah J, Duprez DA, Jacobs DR Jr.. Obesity (Silver Spring). 2015;23(11):2294-2298.

Risk stratification for primary prevention of coronary artery disease: roles of C-reactive protein and coronary artery calcium. Qureshi WT, Rana JS, Yeboah J, Bin Nasir U, Al-Mallah MH.. Curr Cardiol Rep. 2015;17(12):110.

Coronary artery calcium progression and atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. O'Neal WT, Efird JT, Qureshi WT, Yeboah J, Alonso A, Heckbert SR, Nazarian S, Soliman EZ.. Circ Cardiovasc Imaging. 2015;8(12):e003786.

Cancer and its association with the development of coronary artery calcification: an assessment from the Multi-Ethnic Study of Atherosclerosis. Whitlock MC, Yeboah J, Burke GL, Chen H, Klepin HD, Hundley WG.. J Am Heart Assoc. 2015;4(11):e002533.

Class I indications for statin therapy in primary prevention by three cholesterol guidelines and risk of incident cardiovascular outcomes: Multi-ethnic Study of Atherosclerosis (MESA) [abstract]. Flueckiger P, Qureshi W, Blaha M, Burke G, Sandfort V, Michos ED, Herrington D, Yeboah J.. Circulation. 2015;132(Suppl 3):A12490.

The impact of replacing the pooled cohort equation with other CVD risk scores on atherosclerosis cardiovascular disease risk assessment: MESA [abstract]. Qureshi W, Flueckiger P, Blaha M, Michos ED, Sandfort V, Herrington DM, Burke G, Yeboah J.. Circulation. 2015;132(Suppl 3):A10128.

Class I indication for statin therapy in primary prevention by three cholesterol guidelines and prevalence of coronary artery calcium in asymptomatic adults: Multi-ethnic Study of Atherosclerosis (MESA) [abstract]. Flueckiger P, Qureshi W, Blaha M, Burke G, Sandfort V, Michos ED, Herrington D, Yeboah J.. Circulation. 2015;132(Suppl 3):A12119.

Intermediate end point cardiovascular clinical trials: an excellent idea based on an obsolete paradigm. Yeboah J, Herrington DM.. Expert Rev Cardiovasc Ther. 2014;12(2):161-165.

A functionally significant polymorphism in ID3 is associated with human coronary pathology. Manichaikul A, Rich SS, Perry H, Yeboah J, Law M, Davis M, Parker M, Ragosta M, Connelly JJ, McNamara CA, Taylor AM.. PLoS One. 2014;9(3):e90222.

Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study. Cox AJ, Azeem A, Yeboah J, Soliman EZ, Aggarwal SR, Bertoni AG, Carr JJ, Freedman BI, Herrington DM, Bowden DW.. Diabetes Care. 2014;37(5):1454-1461.

Mediation of cardiovascular risk factor effects through subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Yeboah J, Delaney JA, Nance R, McClelland RL, Polak JF, Sibley CT, Bertoni A, Burke GL, Carr JJ, Herrington DM.. Arterioscler Thromb Vasc Biol. 2014;34(8):1778-1783.

Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis. Yeboah J, Carr JJ, Terry JG, Ding J, Zeb I, Liu S, Nasir K, Post W, Blumenthal RS, Budoff MJ.. Eur J Prev Cardiol. 2014;21(10):1233-1241.

Plasma sphingomyelin and longitudinal change in percent emphysema on CT. The MESA lung study. Ahmed FS, Jiang XC, Schwartz JE, Hoffman EA, Yeboah J, Shea S, Burkart KM, Barr RG.. Biomarkers. 2014;19(3):207-213.

Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Yeboah J, Erbel R, Delaney JC, Nance R, Guo M, Bertoni AG, Budoff M, Moebus S, Jockel KH, Burke GL, Wong ND, Lehmann N, Herrington DM, Mohlenkamp S, Greenland P.. Atherosclerosis. 2014;236(2):411-417.

Cardiovascular risk prediction: the old has given way to the new but at what risk-benefit ratio?. Yeboah J.. J Res Rep Clin Cardiol. 2014;5():279-281.

Coronary artery calcium and risk of atrial fibrillation (from the Multi-Ethnic Study of Atherosclerosis). O'Neal WT, Efird JT, Dawood FZ, Yeboah J, Alonso A, Heckbert SR, Soliman EZ.. Am J Cardiol. 2014;114(11):1707-1712.

Left ventricular dilation and incident congestive heart failure in asymptomatic adults without cardiovascular disease: Multi-Ethnic Study of Atherosclerosis (MESA). Yeboah J, Bluemke DA, Hundley WG, Rodriguez CJ, Lima JA, Herrington DM.. J Card Fail. 2014;20(12):905-911.

Brachial flow-mediated dilation and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. O'Neal WT, Efird JT, Yeboah J, Nazarian S, Alonso A, Heckbert SR, Soliman EZ.. Arterioscler Thromb Vasc Biol. 2014;34(12):2717-2720.

Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. the MESA study. Gibson AO, Blaha MJ, Arnan MK, Sacco RL, Szklo M, Herrington DM, Yeboah J.. JACC Cardiovasc Imaging. 2014;7(11):1108-1115.

Targeting specific traditional risk factors to improve cardiovascular outcomes: sound or flawed? [invited commentary]. Yeboah J.. Atherosclerosis. 2013;226(2):335-336.

Association of hemoglobin A1C with cardiovascular disease and all-cause mortality in individuals without diabetes--the Multi-Ethnic Study of Atherosclerosis [abstract]. Azeem A, Yeboah J, Bertoni A, Burke G, Turkbey E, Szklo M, Herrington D.. Circulation. 2013;127(12 Suppl):AP278.

Premature ventricular complexes predict mortality in a population with type 2 diabetes--the Diabetes Heart Study [abstract]. Virgadamo S, Azeem A, Yeboah J, Rodriguez CJ, Cox AJ, Bowden DW, Herrington DM.. Circulation. 2013;127(12 Suppl):AP049.

Weekly doxorubicin increases coronary arteriolar wall and adventitial thickness. Eckman DM, Stacey RB, Rowe R, D'Agostino R Jr, Kock ND, Sane DC, Torti FM, Yeboah J, Workman S, Lane KS, Hundley WG.. PLoS One. 2013;8(2):e57554.

Coronary artery calcium score is an independent predictor of incident stroke in population based adults. Multi-Ethnic Study of Atherosclerosis (MESA) [abstract]. Gibson AO, Yeboah J, Arnan MK, Sacco R, Blaha, M, Szklo M, Herrington D.. Circulation. 2013;128(22 Suppl):A16175.

Metabolomics: the-omics of tomorrow. Qureshi W, Yeboah J.. Metabolomics. 2013;3(3):e130.

Coronary artery calcium score improves the net reclassification index of prevalent cardiovascular disease in African Americans: the Jackson Heart Study [abstract]. Yeboah J, Smith CL, Sims M, Fox E, Ge Y, Wilson JG, Terry JG, Taylor HA Jr, Carr JJ.. Circulation. 2012;125(10 Suppl):AP159.

Association of coronary calcium score with cardiovascular risk factors in African Americans: the Jackson Heart Study [abstract]. Smith CL, Yeboah J, Sims M, Harman JL, Terry JG, Crump ME, Doherty M, Carr JJ, Taylor HA Jr.. Circulation. 2012;125(10 Suppl):AP154.

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, Carr JJ, Goff DC Jr, Greenland P, Herrington DM.. JAMA. 2012;308(8):788-795.

Computed tomography derived cardiovascular risk markers, incident cardiovascular events and all-cause mortality in adults free of clinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis [abstract]. Yeboah J, Carr JJ, Terry JG, Ding J, Zeb I, Liu S, Nasir K, Post W, Blumenthal RS, Budoff M.. Circulation. 2012;126(21 Suppl):A9536.

Heart rate corrected QT interval is an independent predictor of all-cause mortality in a diabetic population--the Diabetes Heart Study [abstract]. Azeem A, Yeboah J, Soliman EZ, Cox A, Bertoni A, Herrington DM, Bowden DW.. Circulation. 2012;126(21 Suppl):A15550.

Prognosis of individuals with asymptomatic left ventricular systolic dysfunction in the Multi-Ethnic Study of Atherosclerosis (MESA). Yeboah J, Rodriguez CJ, Stacey B, Lima JA, Liu S, Carr JJ, Hundley WG, Herrington DM.. Circulation. 2012;126(23):2713-2719.

Markers for prediction of cardiovascular disease risk [reply to letter]. Yeboah J, Greenland P, Herrington DM.. JAMA. 2012;308(24):2561-2562.

Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis). Yeboah J, Bertoni AG, Herrington DM, Post WS, Burke GL.. J Am Coll Cardiol. 2011;58(2):140-146.

Flaws in current clinical trial design: need for intermediate markers [editorial]. Yeboah J.. J Postgenom Drug Biomark Develop. 2011;1():102e.

Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an adult population: MESA. Yeboah J, Redline S, Johnson C, Tracy R, Ouyang P, Blumenthal RS, Burke GL, Herrington DM.. Atherosclerosis. 2011;219(2):963-968.

Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events [reply to letter]. Yeboah J, Bertoni AG, Herrington DM, Post WS, Burke GL.. J Am Coll Cardiol. 2011;58(24):2547.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Cardiology

Clinical Interests

Cardiac Imaging, Preventive Cardiology, Cardiac Magnetic Resonance Imaging, Nuclear Cardiology, Critical Care, Cardiology (clinical), Echocardiography
Joseph Yeboah, M.B.Ch.B.

Joseph Yeboah, M.B.Ch.B.

Assistant Professor, Cardiology
Epidemiology & Prevention

Request An Appointment

Doctor Rating

4.5 out of 5

Joseph Yeboah, M.B.Ch.B.58 Ratings
6 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.6
CP efforts to include in decisions
4.6
CP explanations of prob/condition
4.6
CP spoke using clear language
4.6
Friendliness/courtesy of CP
4.7
Likelihood of recommending CP
4.6
Patients' confidence in CP
4.6
Time CP spent with patient
4.5
Wait time at clinic
4.1



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

9/6/2016

Rushed me into room. Doctor did not have time to talk to me. Nurse ended the session so he could see his next patient.

8/24/2016

Excellent physician & communicate.

6/17/2016

First time seeing *Dr. Yeboah. It was an excellent experience -

6/8/2016

Every single person was GREAT to me!

3/22/2016

Very good.

2/25/2016

Very good experience, good doctor.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.